WADA prohibits ibutamoren at all times under its S2 category (peptide hormones, growth factors, related substances and mimetics), so tested athletes face sanctions for any use
Standard research protocol structure: Loading phase (week 1) : 300mcg daily, initiated 35 days post-injury or surgical repair Active phase (weeks 26) : 300mcg daily, continued through hard callus formation Taper phase (optional, weeks 78) : 150mcg daily or every other day if extending beyond six weeks Daily administration maintains more stable plasma levels than alternate-day or pulsed protocols
Goop this is not, at least not in its aesthetic, though a comparison is apt
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo- and active-controlled, parallel-group, Phase 2 trial conducted in the USA